Costimulatory molecules and autoimmune thyroid diseases.

Area of Science:

• Immunology
• Endocrinology
• Autoimmunity

Background:

• T-cell activation necessitates two signals: antigen recognition via T-cell receptor (TCR) and MHC, and costimulatory signals from cell surface molecules.
• Costimulatory molecules like B7.1/B7.2 interacting with CD28, and CD40/CD40L, are crucial for T-cell proliferation and cytokine secretion.
• Autoimmune thyroid diseases involve antigen presentation by professional and non-professional antigen-presenting cells (APCs), including thyroid follicular cells (TFCs).

Purpose of the Study:

• To investigate the expression of key costimulatory and adhesion molecules on TFCs in Graves' disease (GD) and Hashimoto's thyroiditis (HT).
• To understand how differential expression of these molecules on TFCs influences T-cell responses in these autoimmune thyroid conditions.

Main Methods:

• Analysis of MHC class I and II, CD40, B7.1, and ICAM-1 expression on TFCs from patients with GD and HT.
• Comparison of molecule expression patterns between GD and HT TFCs.

Main Results:

• TFCs in both GD and HT aberrantly express MHC class II and CD40.
• TFCs in HT express B7.1 and ICAM-1, unlike TFCs in GD.
• This differential expression suggests distinct T-cell signaling environments in GD and HT.

Conclusions:

• The presence of B7.1 and ICAM-1 on HT TFCs may promote local T-cell activation, differentiation towards a type 1 cytokine profile, and lymphocyte survival.
• The absence of B7 and ICAM-1 on GD TFCs might lead to T-cell anergy and apoptosis, potentially limiting autoimmune reactions.
• Differential expression of costimulatory molecules by TFCs plays a significant role in the pathogenesis of autoimmune thyroid diseases.